

Most Read This Week
- Immunotherapy in the Treatment of Prostate Cancer
- Dr. Petros Grivas on Switching Jobs: Part 1
- Palbociclib in Combination With Endocrine Therapy vs Capecitabine in HR-Positive, HER2-Negative, Aromatase Inhibitor–Resistant Metastatic Breast Cancer
- Laparoscopic vs Open Gastrectomy for Gastric Cancer
- Advances in Therapeutic Approaches for Triple-Negative Breast Cancer
Recently Updated
- FDA Approves Fam-Trastuzumab Deruxtecan-Nxki for HER2-Positive Gastric Adenocarcinomas
- Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Esophageal Squamous Cell Carcinoma
- Upfront Surgery or Definitive Radiotherapy for p16+ Oropharyngeal Cancer
- Risk for Developing, Dying From Second Cancer Higher for Survivors
- Financial Toxicity Linked to QOL After Breast Cancer Surgery